Přehled studií citovaných v článcích tohoto čísla Kardiologické revue
Vyšlo v časopise:
Kardiol Rev Int Med 2006, 8(3): 147
- ASCOT-LLA – Anglo-Scandinavian Cardiac Outcomes Trial-lipid-lowering arm
- ASPEN – Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent Diabetes Mellitus
- BARI II – Bypass Angioplasty Revascularization Investigation II
- BETACAR – Betaxolol versus Carvedilol in Chronic Heart Failure
- BIPS – Bezafibrat Infarction Prevention Study
- CAPRICORN – Carvedilol Post Infarct Survival Control in LVD
- CAPRIE – Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE) study
- CARDS – Collaborative Atorvastatin Diabetes Study
- CARE – Cholesterol And Recurrent Events
- CIBIS II – The Second Cardiac Insufficiency Bisoprolol Study
- CLARITY – Cladribine Tablets in Treating MS Orally Study
- COMET – Carvedilol or Metoprolol European Trial Study
- COMMIT/CCS-2 – Clopidogrel and Metoprolol in Myocardial Infarction Trial Study
- COPERNICUS – Carvedilol Prospective Randomized Cumulative Survival
- CREDO – The Clopidogrel for the Reduction of Events During Observation Study
- CURE – The Clopidogrel in Unstable Angina to Prevent Recurrent Events
- DAIS – Diabetes Atherosclerosis Intervention Study
- DCCT – Diabetes Control and Complications Trial Study
- DIGAMI – Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction
- DIGAMI II – Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction 2
- EDIC – Epidemiology of Diabetes Interventions and Complications Study
- ETDRS – Early Treatment Diabetic Retinopathy Study
- EUROPA – European Trial on Reduction of Cardiac Events with Perindopril in Stable Artery Coronary Disease
- FIELD – Fenofibrate Intervention and Event Lowering in Diabetes
- GREACE – Greek Atorvastatin and Coronary-heart-disease Evaluation
- HOPE – Heart Outcomes Prevention Study
- HPS – Heart Protection Study
- CHARISMA – Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance
- ISAR – Diabetes Study Paclitaxel-eluting and Sirolimus-eluting stents to Prevent Restenosis in Diabetic Patients
- ISIS-1 – Second International Study of Infarct Survival
- LATE-BASKET – Late Clinical Events Related to Late Stent Thrombosis After Stopping Clopidogrel: Drug-Eluting vs Bare-Metal Stenting
- LIPID – Long-term Intervention with Pravastatin in Ischemic Disease
- MADIT II – Multicenter Automatic Defibrillator Implantation Trial II
- MERIT HF – The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure Study
- MIAMI – Metoprolol in Acute Myocardial Infarction Study
- MIRACLE – Multicenter InSync Randomized Clinical Evaluation
- ONTARGET – Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial Study
- PEACE – Prevention of Events with Angiotensin-Converting Enzyme Inhibition
- PHS – Physicians’ Health Study
- POPADAD – The Prevention of Progression of Asymptomatic Diabetic Arterial Disease Study
- PPP – Primary Prevention Project
- PROACTIVE – Prospective Pioglitazone Clinical Trial in Macro Vascular Events
- SCORE – The Standard Care vs. Corticosteroid for Retinal Vein Occlusion Study
- SENIORS – Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure
- SIRIUS – SirolimUS-Eluting Stent in De Novo Native Coronary Lesions
- STOP NIDDM – Study to Prevent Non-Insulin-Dependent Diabetes Mellitus
- TIMI-2B – Thrombolysis in Myocardial Infarction 2B Study
- TNT – The Treating to New Targets
- UKPDS – United Kingdom Prospective Diabetes Study
- 4S – Scandinavian Simvastatin Survival Study.
Štítky
Dětská kardiologie Interní lékařství Kardiochirurgie KardiologieČlánek vyšel v časopise
Kardiologická revue – Interní medicína
2006 Číslo 3
Nejčtenější v tomto čísle
- Defekt septa síní
- Neinvazivní vyšetření u arteriální hypertenze
- Losartan – víc než pokles krevního tlaku
- Dálkové monitorování implantabilních kardiostimulátorů a kardioverterů-defibrilátorů